Shila Kandel
Role not yet determined Is this you? Add your title
Also affiliated: Chattogram International Dental College and Hospital (2023)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Shila Kandel's research focuses on oncogenic splicing, specifically investigating the regulatory network of EZH2 and exploring antisense correction strategies. Kandel has published on targeting EZH2 oncogenic splicing, aiming to decode its regulatory mechanisms and develop antisense-based corrections. This work contributes to understanding gene expression regulation in neoplastic processes. Kandel's research network includes collaborators such as Preeti Nagar, Mohammad Alinoor Rahman, Md. Rafikul Islam, and Shabiha Afroj Heeamoni, all affiliated with the University of Arkansas for Medical Sciences. Kandel has a recent publication in 2026, indicating ongoing activity in the field. Earlier publications have explored variations in anatomical measurements among students in medical colleges in Nepal.
Metrics
- h-index: 1
- Publications: 4
- Citations: 2
Selected Publications
-
Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction (2026)
-
Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction (2026)
Collaboration Network
Top Collaborators
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 Oncogenic Splicing: Decoding the Regulatory Network and Antisense Correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
- Targeting EZH2 oncogenic splicing: decoding the regulatory network and antisense correction
Similar Researchers
Based on overlapping research topics